Edition:
United States

People: Koninklijke DSM NV (RDSMY.PK)

RDSMY.PK on OTC Markets Group

18.11USD
10:42am EDT
Change (% chg)

$0.77 (+4.44%)
Prev Close
$17.34
Open
$18.00
Day's High
$18.13
Day's Low
$18.00
Volume
6,603
Avg. Vol
50,959
52-wk High
$18.13
52-wk Low
$13.46

de Swaan, Tom 

Mr. Tom de Swaan serves as Deputy Chairman of the Supervisory Board at Royal DSM N.V. Prior to this, he was Member of the Supervisory Board at the Company. He is currently retired. The last position he held was Member of the Managing Board and Chief Financial Officer/Chief Risk Officer ABN AMRO. Mr. de Swaan also served as Non-Executive Director of the Board of GlaxoSmithKline Plc. He is Chairman and Chief Executive Officer of Zurich Financial Services, member Supervisory Board of Van Lanschot Bankiers (chairman until 21 December 2015), chairman Board of Trustees of Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital and chairman Advisory Board Rotterdam School of Management. Mr. de Swaan is Chairman of the Company's Audit Committee and Member of Remuneration Committee. He graduated from University of Amsterdam with a degree in Economics.

Basic Compensation

Total Annual Compensation, EUR 77,167
Restricted Stock Awards, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 2,437
Fiscal Year Total, EUR 79,604

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Routs

96,750

Feike Sijbesma

2,710,000

Tom de Swaan

79,604

Geraldine Matchett

1,656,000

Dimitri de Vreeze

1,683,000

Stephan Tanda

1,782,000
As Of  30 Dec 2016